References
- Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2007;2:501–12.
- Urban C, Rahal JJ. Klebsiella and extended-spectrum β-lactamases. Int J Antimicrob Agents. 1997;8:37–43.
- Yigit H, Quennan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al.. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–61.
- Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother. 2007;52(2):796–7.
- Navon-Venezia S, Chmeltnisky I, Leavitt A, Schwaber MJ, Carmely Y. Plasmid-mediated imipenem hydrolyzing enyzme KPC-2 among carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother. 2006;50:3098–101.
- Giakkoupi P, Xanthaki A, Kanelopoulou M, Vlahaki A, Miringou V, Kontou S, et al.. VIM-1 metallo-β-lactamase-producing Klebsiella pnuemoniae strains in Greek Hospital. J Clin Microbiol. 2003;41(8):3893–6.
- Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerging Infect Dis. 2011;17:103–6.
- Yan JJ, Ko WC, Tsai SH, Wu HM, Wu JJ. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a University Medical Center in Taiwan. J Clin Microbiol. 2001;39:4433–9.
- Aktas Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48 persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy. 2008;54:101–6.
- Gulmez D, Woodford N, Palepou MF, Mushtag S, Metan G, Yakopogulklan Y, et al.. Carbapenem resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48 like carbapenemase and outer membrane protein loss. Int J Antimicrob Agents. 2008;31(6):523–6.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI/NCCLS M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10(4):867–78.
- Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA-double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2003;41:4623–9.
- Walsh TR, Bolmstrom A, Gales A. Evaluation of new E test for detecting metallo-β-lactamases in routine clinical testing J Clin Microbiol. 2002;40:2755–9.
- Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. A sensitive screening test for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol. 2009;47(6):1631–9.
- Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: , Lorian V, ed, editor. Antibiotics in laboratory medicine. 2nd ed. Baltimore, MD: Williams & Wilkins; 1986. p. 683–721.
- Matthew MA, Harris AM, Marshall MJ, Ross GW. The use of isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol. 1975;88:169–78.
- Nüesch-Inderbinen MT, Hächler H, Kayser FH. Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis. 1996;15(5):398–402.
- Arlet G, Brami G, Decre D, Flippo A, Gaillot O, Lagrange PH. Molecular characterization by PCR restriction fragment polymorphism of TEM β-lactamases. FEMS Microbiol Lett. 1995;134(2–3):203–8.
- Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al.. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2004;54(4):735–43.
- Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153–62.
- Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43:4178–82.
- Diestra K, Miro E, Navarro D, Cuquet J, Coll P, Navarro F. Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital. Clin Microbiol Infect. 2011;17(7):1032–6.
- Orsi GB, Garcia-Fernandez A, Giordano A, Venditti C, Bencardino A, Gianfreda R, et al.. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumonae in hospitalized patients. J Hospit Infect. 2011;78(1):54–8.
- Baboue B, Widmer AF, Dubuis O, Ciardo D, Droz S, Betsch BY, et al.. Emergence of four cases of KPC-2 and KPC-3-arrying Klebsiella pneumoniae introduced to Switzerland 2009-10. Euro Surveillance. 2011;16(11): Epub.
- Steinmann J, Kaase M, Gatermann S, Popp W, Steinmann E, Damman M, et al.. Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German University hospital, July 2010 to January 2011. Euro Surveill. 2011;16(33): Epub.
- Bogaerts P, Montasinos I, Rodriguez-Villalobos H, Blairon L, Deplano A. Glupczynski Y. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium. J Antimicrob Chemother. 2010;65:361-376.
- Richter S, Frasson I, Bergo C, Parisi S, Cavallaro A, Palu G. Transfer of KPC-2 carbapenemase from Klebsiella pneumoniae to Escherichia coli in a patient: The first case in Europe. J Clin Microbil. 2011;49(5):2040-2042.
- Li B, Sun JY, Liu QZ, Han LZ, Huang XH, Ni YX. First report of Klebsiella oxytoca strains coproducing KPC-2 and IMP-8 carbapenemases. Antimicrob Agents Chemother. 2011;55(6):2937-2941.